From SAMHSA Expanding Access to and Use of Behavioral Health Services for People At Risk for or Experiencing Homelessness This guide highlights strategies for behavioral health and housing providers to conduct outreach and engage with individuals experiencing homelessness, initiate use of behavioral health treatment as they wait to receive stable housing and retain them in […]
SAMHSA
SAMHSA’s Prevention Day
SAMHSA’s 19th Prevention Day, Monday, January 30, 2023
MOUD Expansion
SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD) January 18, 2023
New Funding to Tackle Mental Health Crisis
From SAMHSA Biden-Harris Administration Announces Millions of Dollars in New Funds for States to Tackle Mental Health Crisis Tuesday, October 18, 2022 In addition to nearly $300 million awarded in September for new and existing Certified Community Behavioral Health Clinics, $15 million in new grants will be awarded early next year thanks to the Bipartisan […]
Adapting EBPs for Under-resourced Populations
From SAMHSA SAMHSA released the guide Adapting Evidence-based Practices for Under-resourced Populations in September 2022. This guide focuses on research supporting adaptations of evidence-based practices (EBPs) for under-resourced populations. Adaptations involve tailoring care, programs, and services to the cultural, social, gender, and demographic contexts of the people served to yield positive outcomes.
Burnout in the BH Workforce
From SAMHSA Addressing Burnout in the Behavioral Health Workforce through Organizational Strategies September 2022 Burnout is a complex issue resulting from chronic workplace stress that encompasses exhaustion, depersonalization, and reduced personal accomplishment. This guide will highlight organization-level interventions to prevent and reduce burnout among behavioral health workers.
Toolkit: Telehealth & OUD
The Telehealth for Opioid Use Disorder Toolkit: Guidance to Support High-Quality Care, released in October 2021, focuses on buprenorphine (typically formulated as buprenorphine/naloxone, hereafter termed buprenorphine) and adjunctive psychotherapy treatment options for OUD and does not cover methadone treatment or XR-naltrexone. The primary goal of this toolkit is to provide clinically relevant information to support […]
New SAMHSA Advisories – Januay 2021
SAMHSA has published a series of Advisories based on existing Treatment Improvement Protocols (TIPs) and Technical Assistance Publications (TAPs). These Advisories summarize updated guidance and recommendations on topics in the substance use disorder (SUD) treatment field. Check them out here.